Body Mass Index As A Prognostic Factor In HER-2 Positive Early Breast Cancer Patients And Its Effect On Duration Of Treatment With Trastuzumab: A Retrospective Study.

Autor: Bardisi SA; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt., ElFeky AM; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt., Ibrahim EI; Department of Clinical Oncology and Nuclear Medicine,Zagazig University,Egypt., Dorgham Y; Department of Clinical Oncology and Nuclear Medicine,Zagazig University,Egypt., Elmongy Sadaka EA; Department of Clinical Oncology and Nuclear Medicine, Kafrelsheikh University,Egypt.

Publikováno v: JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2023 Apr; Vol. 73(Suppl 4) (4), pp. S257-S262.